Original news and analysis on international IP policy
World Health Organization member governments have been working for several years to agree on ways to prevent the spread of dangerous and misleading substandard and fake medical products. Now, they seem to be moving in the direction of concrete action.
The Berne Declaration, a Swiss non-profit, has released results of investigations that found industry-sponsored offshore clinical drug trials in developing countries involve "multiple ethical violations," a problem increased by the patent-based industry business model.
The Medicines Patent Pool today announced a new agreement with biopharmaceutical company Bristol-Myers Squibb for an HIV medicine, which is expected to increase access in 110 developing countries.
CAPE TOWN, SOUTH AFRICA - Public groups this week urged Mark Dybul, head of the Geneva-based Global Fund for HIV, Tuberculosis and Malaria, to reconsider the establishment of a panel to look at tiered pricing for middle income countries, potentially allowing companies to charge them higher prices. And separately, activists reported on progress in South Africa's HIV strategy.
CAPE TOWN, SOUTH AFRICA - Intellectual property rights represent a hurdle to lower-priced, high quality tests of HIV treatment monitoring in developing countries, public health group Médecins Sans Frontières (MSF, Doctors without Borders) said today.
The World Intellectual Property Organization has issued a press release hailing the completion of a Creative Commons licence for intergovernmental organisations (IGOs) to offer their published material for others to share with minimal restrictions. WIPO was joined by a wide range of other IGOs such as the Organization for Economic Cooperation and Development (OECD), numerous United Nations agencies like the World Health Organization, and Creative Commons founder Prof. Larry Lessig.
A group of experts summoned to select projects presenting innovative ways to foster research and development of medical products for diseases primarily affecting developing countries at the World Health Organization this week finished their work and selected eight projects out of 22. Civil society was quick to express concern that the selected projects do not propose a new way forward. Now WHO member states must narrow the list down further.
The regions of the World Health Organization earlier this month submitted their proposals for projects to boost research and development of health technologies for diseases disproportionately affecting developing countries and lacking a market incentive. A shortlist of projects will be selected by a group of WHO-chosen experts at a 3-5 December meeting in Geneva.
Ten global health organisations today launched "Fight the Fakes," a global campaign against "fake" medicines, aimed at raising awareness about medicines - brand or generic - that are not what they claim to be. Meanwhile, a Swiss pharmaceutical company official was named head of investigations at a top international public health organisation.
A study emphasising the positive effect of the patent system on the public domain was presented this week by two of its co-authors as a side event to the World Intellectual Property Organization committee on development.
Global health diplomacy was the subject of a symposium organised by the Geneva-based Graduate Institute this week. The symposium explored the crossing lines between health diplomacy and science diplomacy, in particular how can diplomacy facilitate international scientific cooperation in health. This week was also the one-year anniversary of the World Health Organization protocol against illicit trade in tobacco products.
Years-old efforts by members of the World Health Organization to come up with viable ways to boost research and development of medical products for diseases primarily affecting poor populations are coming to head, with a key meeting in December. That meeting of experts will be an opportunity to narrow down proposals being developed by the six WHO regional offices.